Results 101 to 110 of about 30,070 (260)

Editorial: Membrane Processes in Erythroid Development and Red Cell Life Time

Frontiers in Physiology, 2021
Giampaolo Minetti, Anna Rita Migliaccio, Anna Rita Migliaccio, Eitan Fibach   +3 more
doaj   +1 more source

Myeloproliferative neoplasm stem cells

, 2017
Myeloproliferative neoplasms (MPNs) arise in the hematopoietic stem cell (HSC) compartment as a result of the acquisition of somatic mutations in a single HSC that provides a selective advantage to mutant HSC over normal HSC and promotes myeloid ...
Mead, Adam, Mullally, A, Ann Mullally, Adam J. Mead, Mead, A   +4 more
core   +1 more source

Delayed Gastric Bleeding in a Patient With Chronic Myeloid Leukemia: A Case of Post‐Biopsy Bleeding

DEN Open, Volume 7, Issue 1, April 2027.
The presence of underlying conditions, particularly malignancies such as myeloproliferative disorders, may increase the risk of delayed bleeding following gastric mucosal biopsy, and similar cases warrant careful accumulation and evaluation in future. ABSTRACT A 76‐year‐old man was referred to our hospital for evaluation of anemia.
Yoko Kosaka, Hiromichi Yamane, Hidekazu Nakanishi, Nagio Takigawa   +3 more
wiley   +1 more source

Coexistence of chronic lymphocytic leukemia and polycythemia vera: a case report and review of the literature

Annals of Saudi Medicine, 2016
Polycythemia vera is a Philadelphia chromosome-negative myeloproliferative neoplasm. Chronic lymphocytic leukemia is a monoclonal expansion of a CD5+ CD19+ B lymphocytes.
Serdal Korkmaz, Sinan Kulakoglu, Hasan Gorkem, Bilal Aygun, Ali Cetinkaya   +4 more
doaj   +1 more source

Venetoclax‐Integrated Conditioning Strategies Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Myeloid Neoplasms: A Scoping Review of Emerging Evidence

European Journal of Haematology, Volume 117, Issue 1, Page 117-131, July 2026.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) remains the only potentially curative therapy for many patients with high‐risk myeloid neoplasms, yet relapse and transplant‐related toxicity continue to limit durable benefit.
Mohammed Abdulgayoom, Amaal Gulied, Awni Alshurafa, Shehab F. Mohamed, Mohamed A. Yassin, Afraa Fadul   +5 more
wiley   +1 more source

AXL inhibition extinguishes primitive JAK2 mutated myeloproliferative neoplasm progenitor cells

, 2019
Myeloproliferative neoplasms (MPN) are clonal stem cell associated disorders inclusive of chronic myeloid leukaemia (CML), Polycythaemia vera (PV), myelofibrosis (MF), and essential thrombocythemia (ET).
Somervaille, Timothy, Pearson, Stella, Pierce, Andrew; id_orcid, Anthony D. Whetton, Tim C.P. Somervaille, Stella Pearson, Rognvald Blance, Andrew Pierce, Blance, Rognvald, Whetton, Anthony; id_orcid   +9 more
core   +1 more source

Factors Influencing Evidence‐Informed Symptom Management in Outpatient Malignant Hematology: A Qualitative Description of Patients' and Nurses' Experiences

Journal of Clinical Nursing, Volume 35, Issue 7, Page 3226-3241, July 2026.
ABSTRACT Aims To describe patients' and oncology nurses' experiences with symptom management care, and influential barriers and facilitators to enhancing evidence‐informed symptom management in an outpatient malignant hematology unit. Design A qualitative descriptive study embedded within an experience‐based co‐design approach.
Kylie Teggart, Denise Bryant‐Lukosius, Sarah E. Neil‐Sztramko, Tammy De Gelder, Kari Kolm, Cheryl Page, Rebecca Ganann   +6 more
wiley   +1 more source

Genomic profiling for thrombosis risk prediction in myeloproliferative neoplasms

Bleeding, Thrombosis and Vascular Biology
The main BCR-ABL-negative myeloproliferative neoplasms consist of polycythemia vera, essential thrombocythemia and primary myelofibrosis. They have been associated with an overall elevated risk of thromboembolism, including both venous and arterial ...
Simon Mantha
doaj   +1 more source

FLT3-ITD Knockin Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to Myeloproliferative Neoplasm

, 2012
SummaryInternal tandem duplication (ITD) mutations within the FMS-like tyrosine kinase-3 (FLT3) render the receptor constitutively active driving proliferation and survival in leukemic blasts.
Chu, S. Haihua, Li, Li, Kaplan, Ian, Small, Don, Heiser, Diane, Collector, Michael, Huso, David, Civin, Curt, Sharkis, Saul J.   +8 more
core   +1 more source

Atypical Myocardial Infarction with Apical Thrombus and Systemic Embolism: A Rare Presentation of Likely JAK2 V617F-Positive Myeloproliferative Neoplasm

, 2020
A few types of myeloproliferative neoplasms may be significant for Janus-associated kinase 2 mutation, JAK2 V617F, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Lloyd Muzangwa, Rana Al-Zakhari, Muhammed Atere, Francesco Rotatori, Jennifer Collins   +4 more
core   +1 more source